3507-48-0 Usage
Uses
Used in Pharmaceutical Industry:
2-Benzothiazolecarboxylicacid,4-methoxy-(7CI,8CI,9CI) is utilized as an intermediate in the manufacturing process of pharmaceuticals. Its unique structure and properties contribute to the development of new drugs and medications, enhancing their efficacy and potential applications in treating various health conditions.
Used in Agrochemical Industry:
In the agrochemical sector, 2-Benzothiazolecarboxylicacid,4-methoxy-(7CI,8CI,9CI) serves as a key intermediate in the synthesis of agrochemicals. Its incorporation into these products helps improve their performance, such as enhancing crop protection and increasing yield.
Used in Chemical Reactions and Organic Synthesis:
2-Benzothiazolecarboxylicacid,4-methoxy-(7CI,8CI,9CI) is employed in various chemical reactions and organic synthesis processes. Its reactivity and functional groups make it a valuable component in creating new compounds and materials with specific properties and applications.
Used in Material Development:
2-Benzothiazolecarboxylicacid,4-methoxy-(7CI,8CI,9CI) also has potential applications in the development of new materials and compounds. Its unique structure and properties can be leveraged to create innovative materials with improved characteristics, such as enhanced stability, reactivity, or selectivity, depending on the specific application and formulation.
Check Digit Verification of cas no
The CAS Registry Mumber 3507-48-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,5,0 and 7 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 3507-48:
(6*3)+(5*5)+(4*0)+(3*7)+(2*4)+(1*8)=80
80 % 10 = 0
So 3507-48-0 is a valid CAS Registry Number.
3507-48-0Relevant academic research and scientific papers
Lysophosphatidic acid receptor antagonists and preparation method thereof
-
Paragraph 0709-0710; 0718-0720, (2020/07/29)
The invention belongs to the technical field of medicinal chemistry, and particularly relates to lysophosphatidic acid receptor antagonists and a preparation method thereof. The applicant surprisinglyfinds that compounds provided by the invention have high LPAR1 antagonistic activity and selectivity, low toxicity, good metabolic stability and good drug development prospect, and can be used for preventing or treating diseases or symptoms related to LPAR1. The applicant also accidentally finds that the IC50 value of part of the compounds can be as low as 300 nM or below and even 50 nM or below.Moreover, the compounds disclosed by the invention have better safety, and the CC50 range of the compounds can reach 200 [mu]M or above. In addition, the compounds of the present invention have goodmetabolic stability in humans, rats, and mice, such excellent inhibitory activity being very desirable for their use as LPAR1 inhibitors in the above diseases or disorders. In addition, the preparation method of the compounds is simple, mild in reaction condition, high in product yield and suitable for industrial production.
